CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Double Blind Study of Pancreatic Enzyme Replacement Therapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05642962
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:21.093242+00:00
Published At: 2026-02-25T00:00:00+00:00
Record Updated At: 2026-02-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Pancreatic Ductal Adenocarcinoma", "Metastatic Pancreatic Cancer", "Metastatic Pancreatic Adenocarcinoma", "Metastatic Pancreatic Carcinoma", "Pancreatic Carcinoma", "Pancreatic Carcinoma Metastatic", "Pancreatic Carcinoma Non-resectable", "Pancreatic Cancer", "Pancreatic Cancer Non-resectable", "Pancreatic Cancer Stage IV", "Pancreatic Cancer Metastatic", "PDAC", "PDAC - Pancreatic Ductal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-02-25"
protocolSection.identificationModule.nctId: "NCT05642962"
protocolSection.identificationModule.officialTitle: "A Randomized Double Blind Study of Pancreatic Enzyme Replacement Therapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.